BH02 Overcoming Genetic Drivers in Alopecia Areata: Hair Regrowth in a Patient with the AIRE Gene Mutation Treated with Ruxolitinib
June 2025
in “
British Journal of Dermatology
”
A 20-year-old woman with alopecia universalis and a biallelic AIRE gene mutation, associated with APECED, achieved complete hair regrowth (SALT score of 0) after 9 months of treatment with ruxolitinib, a Janus kinase inhibitor. The treatment also improved her neurological condition and quality of life. This case underscores the potential of ruxolitinib in treating severe alopecia areata linked to genetic mutations.